Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Mol Cancer Res. 2017 May 23;15(8):1063–1072. doi: 10.1158/1541-7786.MCR-17-0062

Figure 1. Aurora A kinase inhibitors attenuate 2-ME induced AR degradation.

Figure 1

(A-B) LNCaP and C4-2, (C) 22RV1 and (D) LAPC4 cells were treated with or without 2-ME in presence or absence of Aurora A kinase inhibitor MLN8054 and/or VX-680 for 24 h. Cells were harvested, lysed and extracts were immunoblotted for indicated proteins. Tubulin served as loading control.